Activity record

PGDB_A080957

Assay: biochemicalTarget: CRBNQC: standardized
Activity overview

inhibition = 53-60 %

TargetCRBN
E3 ligaseCRBN
Concentration0.5 uM
Assay / ReadoutHTRF / % Inhibition
Assay IDPGDB_AS000662
PatentWO2026061475A1
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C030431
Compound IDPGDB_C030431
CompoundGT-11091
Source record IDPGDB_C030431
InChIKeyGDRPKVHDVGUHSK-UHFFFAOYSA-N

Assay context

Assay IDPGDB_AS000662
Assay familybiochemical
Assay systemcell_based
Readout% Inhibition
TechnologyHTRF
Concentration0.5 uM
Detection targetcell_inhibition
TargetCRBN
E3CRBN
OrganismHomo sapiens

Source evidence

Patent IDWO2026061475A1
Compound location

GT-11091

GT-11091 enlarged structureGT-11091 location on patent page 88
Activity table
Page 215 · table start
Page 216 · table end